HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells.

Abstract
The role of immune responses in tumor development is a central issue for tumor biology and immunology. IL-17 is an important cytokine for inflammatory and autoimmune diseases. Although IL-17-producing cells are detected in cancer patients and tumor-bearing mice, the role of IL-17 in tumor development is controversial, and mechanisms remain to be fully elucidated. In the current study, we found that the development of tumors was inhibited in IL-17R-deficient mice. A defect in IFN-gammaR increased tumor growth, whereas tumor growth was inhibited in mice that were deficient in both IL-17R and IFN-gammaR compared with wild-type animals. Further experiments showed that neutralization of IL-17 by Abs inhibited tumor growth in wild-type mice, whereas systemic administration of IL-17 promoted tumor growth. The IL-17R deficiency increased CD8 T cell infiltration, whereas it reduced the infiltration of myeloid-derived suppressor cells (MDSCs) in tumors. In contrast, administration of IL-17 inhibited CD8 T cell infiltration and increased MDSCs in tumors. Further analysis indicated that IL-17 was required for the development and tumor-promoting activity of MDSCs in tumor-bearing mice. These data demonstrate that IL-17-mediated responses promote tumor development through the induction of tumor-promoting microenvironments at tumor sites. IL-17-mediated regulation of MDSCs is a primary mechanism for its tumor-promoting effects. The study provides novel insights into the role of IL-17 in tumor development and has major implications for targeting IL-17 in treatment of tumors.
AuthorsDonggou He, Hui Li, Nabiha Yusuf, Craig A Elmets, Jun Li, John D Mountz, Hui Xu
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 184 Issue 5 Pg. 2281-8 (Mar 01 2010) ISSN: 1550-6606 [Electronic] United States
PMID20118280 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antibodies
  • Interleukin-17
  • Receptors, Interferon
  • Receptors, Interleukin-17
  • interferon gamma receptor
Topics
  • Animals
  • Antibodies (immunology, pharmacology)
  • Apoptosis (immunology)
  • CD8-Positive T-Lymphocytes (immunology, pathology)
  • Cell Line, Tumor
  • Flow Cytometry
  • In Situ Nick-End Labeling
  • Interleukin-17 (immunology, pharmacology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Myeloid Cells (immunology, pathology)
  • Neoplasms, Experimental (genetics, immunology, pathology)
  • Receptors, Interferon (deficiency, genetics, immunology)
  • Receptors, Interleukin-17 (deficiency, genetics, immunology)
  • Tumor Burden (drug effects, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: